# Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus

> **NCT00539994** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 57 (actual)

## Conditions studied

- Infections, Bacterial

## Interventions

- **DRUG:** retapamulin
- **DRUG:** Retapamulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00539994
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539994, "Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00539994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*